CymaBay Therapeutics Inc. (CBAY)

NASDAQ: CBAY · IEX Real-Time Price · USD
2.77
-0.18 (-6.10%)
Jul 1, 2022 4:00 PM EDT - Market closed

Stock Price Forecast

According to 14 stock analysts, the average 12-month stock price forecast for CBAY stock is $10.09, which predicts an increase of 264.26%. The lowest target is $7.07 and the highest is $14.7. On average, analysts rate CBAY stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $7.07 $10.09 $10.2 $14.7
Change +155.23% +264.26% +268.23% +430.69%

Analyst Ratings

The average analyst rating for CBAY stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '22Feb '22Mar '22Apr '22May '22Jun '22
Strong Buy 555555
Buy 1010101098
Hold 111111
Sell 000000
Strong Sell 000000
Total 161616161514

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
8.01M
EPS This Year
-1.26
EPS Next Year
-1.32
Year 2017201820192020202120222023202420252026
Revenue
10.00M-----8.01M58.35M143.01M357.53M
Revenue Growth
-------
628.05%
145.10%
150.00%
EPS
-0.79-1.25-1.53-0.74-1.27-1.26-1.32-0.92-1.01-1.14
EPS Growth
----------
No. Analysts -----109955

Revenue Forecast

Revenue 20222023202420252026
High n/a 57.8M 181.1M 150.2M 371.8M
Avg n/a 8.0M 58.3M 143.0M 357.5M
Low n/a n/a n/a 138.7M 346.8M

Revenue Growth

Revenue Growth 20222023202420252026
High - -
2,160.0%
157.4%
160.0%
Avg - -
628.1%
145.1%
150.0%
Low - - -
137.7%
142.5%

EPS Forecast

EPS 20222023202420252026
High -1.00 -0.86 0.20 -1.07 -1.19
Avg -1.26 -1.32 -0.92 -1.01 -1.14
Low -1.34 -1.43 -1.45 -0.98 -1.11

EPS Growth

EPS Growth 20222023202420252026
High - - - - -
Avg - - - - -
Low - - - - -